Welcome to our dedicated page for Astronova SEC filings (Ticker: ALOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AstroNova, Inc. (NASDAQ: ALOT) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries that help explain key points for investors. AstroNova is a Rhode Island corporation listed on the NASDAQ Global Market, and it files annual, quarterly and current reports, proxy statements and other documents with the U.S. Securities and Exchange Commission.
Through this page, users can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe AstroNova’s Product Identification and Aerospace segments, risk factors, credit facilities, non-GAAP metrics and overall financial condition. These filings detail how the company’s digital product identification solutions and aerospace printing, avionics and data acquisition products contribute to its results, and they explain management’s use of measures such as Adjusted EBITDA and segment-level non-GAAP operating income.
Investors can also access current reports on Form 8-K that disclose material events, including amendments to the company’s Amended and Restated Credit Agreement with Bank of America, leadership changes, cooperation agreements with shareholders, board appointments and the outcomes of annual shareholder meetings. For example, 8-K filings describe the Sixth Amendment to the credit agreement, the appointment of a new President and Chief Executive Officer, and the Cooperation Agreement with Askeladden Capital Management LLC.
AstroNova’s proxy materials on Schedule 14A provide detail on corporate governance, board composition, executive compensation and shareholder proposals. These documents outline features such as one-share, one-vote, board independence, committee structures and advisory votes on executive pay and auditor ratification.
Stock Titan’s interface surfaces these filings in real time as they are posted to EDGAR and applies AI analysis to highlight important sections, summarize complex credit agreement terms, and clarify the implications of leadership or governance changes. Users can also review ownership and transaction-related filings, such as Forms 3, 4 and 5 when available, to track insider holdings and changes.
By using this page, investors gain a structured view of AstroNova’s regulatory history, from its financial reporting and non-GAAP reconciliations to its capital structure, covenants and board-level decisions, with AI tools that make lengthy documents more accessible.
AstroNova, Inc. reported the results of its annual shareholder meeting held on December 2, 2025. A total of 7,638,423 shares of common stock were outstanding as of October 13, 2025, the record date for the meeting.
Shareholders elected seven directors to serve until the next annual meeting and until their successors are elected and qualified. They also approved an advisory, non-binding proposal on the compensation paid to the company's executive officers, with 4,485,855 votes for, 34,705 against, 3,905 abstentions and 2,549,495 broker non-votes. In a separate advisory vote on how often to hold future say-on-pay votes, 4,089,313 votes favored a 1-year frequency, 3,518 favored 2 years, 431,387 favored 3 years, and 248 abstained, with 2,549,494 broker non-votes. Shareholders further ratified the appointment of Wolf & Company, P.C. as independent registered public accounting firm for the fiscal year ending January 31, 2026, by a vote of 7,064,130 for, 6,440 against and 3,390 abstaining.
AstroNova (ALOT) amended its credit agreement with Bank of America. The change raises the revolving commitment to $27,500,000 until July 31, 2026 (then $25,000,000), extends the revolver maturity to August 4, 2028, and refinances prior term debt into a new $10,000,000 Term Loan and a new $9,720,000 Term A-2 Loan. At closing, the company borrowed both term loans and $1,500,000 on the revolver; proceeds were used primarily to repay and refinance existing term loans and pay related costs. The facility remains available for general corporate purposes. The company currently has $17.9 million drawn on the amended revolver.
Repayment terms include quarterly $500,000 installments on the Term Loan through July 31, 2028 with the balance due August 4, 2028, and monthly $40,500 installments on the Term A-2 Loan through July 31, 2035 with the balance due August 4, 2035. Borrowings bear interest at Term SOFR or a floating base rate plus margins of 1.60%–3.25% (or 0.60%–2.25% for base rate), and a commitment fee of 0.15%–0.40% applies to undrawn revolver amounts. Multi‑currency options remain, along with customary covenants and collateral, and the amendment removes the minimum consolidated interim fixed charge coverage ratio.
AstroNova, Inc. (ALOT) calls its 2025 Annual Meeting for December 2, 2025 at 9:00 a.m. EST, held virtually. Shareholders of record at the close of business on October 13, 2025 may vote; there were 7,638,423 common shares outstanding on the record date. Previously mailed proxy cards for the earlier meeting will not be counted and new voting instructions are required.
The Board recommends: FOR the election of seven directors; FOR the advisory vote on executive compensation; 1‑YEAR for the frequency of future say‑on‑pay votes; and FOR ratifying the independent auditor. The slate reflects a governance refresh, including Executive Chairman Darius G. Nevin and CEO/director Jorik Ittmann (appointed August 15, 2025), plus independent director Shawn W. Kravetz, added under an August 21, 2025 Cooperation Agreement with Askeladden Capital Management and Samir Patel.
Compensation highlights note a tougher fiscal 2025: Adjusted EBITDA was $12,335,000, below the STIP threshold of $19,000,000, so no fiscal 2025 STIP bonuses were paid to named executives. The company introduced updated fiscal 2026 incentive metrics and granted stock‑settled performance awards tied to multi‑year revenue growth and adjusted EPS, along with time‑based RSUs to key executives.
Padraig Finn, Senior Vice President of AstroNova, Inc. (ALOT), received equity awards on 09/23/2025. The filing shows an acquisition of 600 shares of common stock at a $0 price and 600 restricted stock units (RSUs) that represent the right to 600 additional shares, bringing his total reported beneficial ownership to 1,200 shares. The RSUs vest in two equal annual installments beginning on 09/23/2026.
This Form 4 documents a routine, non-cash equity grant to an officer; it does not report any cash purchase or sale proceeds and was signed by a power of attorney on 09/25/2025.
AstroNova, Inc. (ALOT) reported interim filing details showing financing, segment and expense updates for the periods ended July 31, 2025 and August 3, 2024. The Product ID segment derives approximately 80% of its revenue from recurring supplies, parts and service. Fair-value estimates for acquired intangibles used a 0.75% relief-from-royalty rate and a 15.5% discount rate for trademark valuation. Credit agreements were amended to temporarily increase the revolving facility to $30.0 million until January 31, 2025, and the company borrowed EUR 14.0 million on a Term A-2 loan plus amounts under the revolving facility to fund a purchase. The Term A-2 loan requires quarterly principal payments through April 30, 2027 and a full payment on August 4, 2027. Interest rates on facilities vary by leverage, with EURIBOR-based margins of 1.60%–2.85%; other borrowing includes an equipment loan at 7.06% (monthly payments of $16,296 through Jan 23, 2029) and an MTEX term loan at 6.022% with monthly payments of EUR 17,402 ($18,795) through Dec 21, 2033. The company expects $3.0 million of annualized savings from restructuring actions. For six months, selling and marketing expense declined to $11.3 million (down 8.9%), G&A rose to $10.0 million (up 18.0%) including nonrecurring charges, and R&D was $3.1 million (4.2% of revenue). Equity plan and director compensation amendments and outstanding share counts are described; employees delivered 2,739 shares to cover taxes on vesting at an average market value of $9.01 per share.
AstraNova, Inc. filed a current report to let investors know it has released financial results for its fiscal second quarter ended July 31, 2025. On September 9, 2025, the company issued a press release with these quarterly results, which is included as Exhibit 99.1 to the report and incorporated by reference.
The company notes that the earnings information in this report and in the attached press release is being furnished rather than filed, which limits how it is treated under certain securities law liability provisions and how it may be incorporated into other SEC filings.
AstroNova, Inc. (ALOT) reporting person Padraig Finn received 43,591 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to one share of common stock and is scheduled to vest and settle on 08/15/2028. The reported RSUs show 43,591 shares beneficially owned following the transaction and are held directly. The filing was signed by Daniel Clevenger by power of attorney on 09/08/2025.
AstroNova, Inc. (ALOT) director Richard S. Warzala received a restricted stock award of 3,471 shares on 08/28/2025 under the company's Amended and Restated Non-Employee Director Annual Compensation Program. The award was reported as having a price of $0 (restricted grant), and after the transaction the reporting person beneficially owned 67,866 shares. The Form 4 was signed by power of attorney on 09/02/2025. The filing reflects a routine, compensatory equity grant to a non-employee director and does not disclose cash consideration or derivative transactions.
Yvonne Schlaeppi, a director of AstroNova, Inc. (ALOT), received a restricted stock award of 3,196 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. The shares were granted at a price of $0 and, after the award, the reporting person beneficially owned 44,426.954 shares. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025. The filing documents a routine, non-derivative equity grant to a director as part of standard board compensation.
FAQ
What is the current stock price of Astronova (ALOT)?
What is the market cap of Astronova (ALOT)?
